By Justin Petrone

CombiMatrix has received a clinical laboratory permit from the New York State Department of Health. The Irvine, Calif.-based molecular diagnostics firm can immediately begin receiving specimens from New York residents for its DNAarray postnatal developmental testing service, according to the firm's CEO.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.